HFX is the sum of excellence in four key areas to support you in providing your patients the best care.
Recently approved by the FDA with a specific indication for Non-Surgical Back Pain (NSBP) patients.
The SCS system approved by the FDA with a specific indication for painful diabetic neuropathy.
A versatile neuromodulation platform designed for enduring patient success.
Learn About Omnia™ Powered By Hfx Connect
End-to-end partnership with you, supporting patient care and optimal outcomes.
Offering maximum versatility with multiple mechanisms to meet the diverse needs of your patients.
Nevro pursues clinical research to better support healthcare providers in treating chronic pain. No other spinal cord stimulation (SCS) technology has this wealth of quality clinical data to back its technology.
At Nevro, our success is measured by our patients satisfaction. 88% percent of patients treated with 10 kHz Therapy are more independent because of their reduced pain.1
Access to the clinical evidence portfolio supporting 10 kHz Therapy
Instructions for use and product manuals, including MRI guidelines
Services to support reimbursement and patient access to Nevro products